Repligen (RGEN) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.07% |
| Dec 31, 2025 | 12.11% |
| Sep 30, 2025 | 16.26% |
| Jun 30, 2025 | 15.34% |
| Mar 31, 2025 | 11.61% |
| Dec 31, 2024 | 13.70% |
| Sep 30, 2024 | 48.66% |
| Jun 30, 2024 | 26.66% |
| Mar 31, 2024 | 21.61% |
| Dec 31, 2023 | 20.74% |
| Sep 30, 2023 | 18.06% |
| Jun 30, 2023 | 15.87% |
| Mar 31, 2023 | 26.18% |
| Dec 31, 2022 | 27.55% |
| Sep 30, 2022 | 27.63% |
| Jun 30, 2022 | 36.10% |
| Mar 31, 2022 | 38.90% |
| Dec 31, 2021 | 41.05% |
| Sep 30, 2021 | 39.61% |
| Jun 30, 2021 | 44.42% |
| Mar 31, 2021 | 47.79% |
| Dec 31, 2020 | 37.12% |
| Sep 30, 2020 | 33.92% |
| Jun 30, 2020 | 33.02% |
| Mar 31, 2020 | 43.02% |
| Dec 31, 2019 | 54.52% |
| Sep 30, 2019 | 42.89% |
| Jun 30, 2019 | 40.93% |
| Mar 31, 2019 | 60.75% |
| Dec 31, 2018 | 53.94% |
| Sep 30, 2018 | 68.31% |
| Jun 30, 2018 | 53.04% |
| Mar 31, 2018 | 55.42% |
| Dec 31, 2017 | 45.94% |
| Sep 30, 2017 | 44.51% |
| Jun 30, 2017 | 47.43% |
| Sep 30, 2016 | 39.23% |
| Jun 30, 2016 | 32.16% |
| Mar 31, 2016 | 29.31% |
| Dec 31, 2015 | 30.79% |
| Sep 30, 2015 | 140.29% |
| Jun 30, 2015 | 30.24% |